CRUSADE: Is it still a good score to predict bleeding in acute coronary syndrome?

Manzano-Fernández, 2016, Am J Cardiol, 117, 1047, 10.1016/j.amjcard.2015.12.048 Steg, 2011, Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology, Eur Heart J, 32, 1854, 10.1093/eurheartj/ehr204 Mehran, 2011, Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium, Circulation, 123, 2736, 10.1161/CIRCULATIONAHA.110.009449 Eikelboom, 2006, Adverse impact of bleeding on prognosis in patients with acute coronary syndromes, Circulation, 114, 774, 10.1161/CIRCULATIONAHA.106.612812 Rao, 2005, Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes, Am J Cardiol, 96, 1200, 10.1016/j.amjcard.2005.06.056 Amsterdam, 2014, 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, e139, 10.1016/j.jacc.2014.09.017 Subherwal, 2009, Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score, Circulation, 119, 1873, 10.1161/CIRCULATIONAHA.108.828541 Ariza-Solé, 2013, CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention, Thromb Res, 132, 652, 10.1016/j.thromres.2013.09.019 Abu-Assi, 2012, Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome, Eur Heart J Acute Cardiovasc Care, 1, 222, 10.1177/2048872612453924 Roffi, 2016, Eur Heart J, 37, 267, 10.1093/eurheartj/ehv320 Thygesen, 2007, Universal definition of myocardial infarction, Eur Heart J, 28, 2525, 10.1093/eurheartj/ehm355 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 1993, An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction, N Engl J Med, 329, 673, 10.1056/NEJM199309023291001 Hanley, 1982, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, 143, 29, 10.1148/radiology.143.1.7063747 Lemeshow, 1982, A review of goodness of fit statistic for use in the development of logistic regression models, Am J Epidemiol, 115, 92, 10.1093/oxfordjournals.aje.a113284 Fox, 2010, Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events, Eur Heart J, 31, 667, 10.1093/eurheartj/ehp499 Spencer, 2007, Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?, Circulation, 116, 2793, 10.1161/CIRCULATIONAHA.107.694273 Ariza-Solé, 2015, Predictive ability of bleeding risk scores in the routine clinical practice, Eur Heart J Acute Cardiovasc Care, 4, 205, 10.1177/2048872614538405 Amador, 2011, Comparison of ischemic and bleeding risk scores in non-ST elevation acute coronary syndromes, Acute Card Care, 13, 68, 10.3109/17482941.2011.567287 Faustino, 2014, Non-ST-elevation acute coronary syndromes in octogenarians: applicability of the GRACE and CRUSADE scores, Rev Port Cardiol, 33, 617, 10.1016/j.repc.2014.01.025 Ariza-Solé, 2014, Efficacy of bleeding risk scores in elderly patients with acute coronary syndromes, Rev Esp Cardiol, 67, 463, 10.1016/j.recesp.2013.10.010 Mehran, 2010, A risk score to predict bleeding in patients with acute coronary syndromes, J Am Coll Cardiol, 55, 2556, 10.1016/j.jacc.2009.09.076 Moscucci, 2003, Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE), Eur Heart J, 24, 1815, 10.1016/S0195-668X(03)00485-8 Nikolsky, 2007, Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach, Eur Heart J, 28, 1936, 10.1093/eurheartj/ehm194 Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327 Flores-Ríos, 2013, Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: insights from a cohort of 1391 patients, Eur Heart J, 2, 19 Valgimigli, 2015, Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial, Lancet, 385, 2465, 10.1016/S0140-6736(15)60292-6 Vranckx, 2017, Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation, Eur Heart J, 38, 1069, 10.1093/eurheartj/ehx048 Feit, 2007, Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial, Am J Cardiol, 100, 1364, 10.1016/j.amjcard.2007.06.026 Doyle, 2008, Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005, JACC Cardiovasc Interv, 1, 202, 10.1016/j.jcin.2007.12.006 Chhatriwalla, 2013, Association between bleeding events and in-hospital mortality after percutaneous coronary intervention, JAMA, 309, 1022, 10.1001/jama.2013.1556 Sciahbasi, 2009, Am J Cardiol, 103, 796, 10.1016/j.amjcard.2008.11.049 Romagnoli, 2012, Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLESTEACS (Radial Versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome) study, J Am Coll Cardiol, 60, 2481, 10.1016/j.jacc.2012.06.017 Généreux, 2011, Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial, EuroIntervention, 7, 905, 10.4244/EIJV7I8A144 Jolly, 2011, Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial, Lancet, 377, 1409, 10.1016/S0140-6736(11)60404-2 Yusuf, 2006, Comparison of fondaparinux and enoxaparin in acute coronary syndromes, N Engl J Med, 254, 1464 Correia, 2015, Comparison of ACUITY and CRUSADE scores in predicting major bleeding during acute coronary syndrome, Arq Bras Cardiol, 105, 20 Boersma, 1999, Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention, Circulation, 100, 2045, 10.1161/01.CIR.100.20.2045 Stone, 2008, Bivalirudin during primary PCI in acute myocardial infarction, N Engl J Med, 358, 2218, 10.1056/NEJMoa0708191 Ibanez, 2017, Eur Heart J Bellemain-Appaix, 2014, Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis, BMJ, 349 Montalescot, 2013, Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes, N Engl J Med, 369, 999, 10.1056/NEJMoa1308075